Stem Cells to Deliver Potential Cure for Back Pain

Chronic back pain could become a thing of the past thanks to a patients own stem cells. Treatment will be available in three years said a team of researchers from the University of Manchester.

The soft shock-absorbing discs which separate the vertebrae in the spine are being rebuilt using stem cells. The researchers are in route to perfecting the technique.

Affecting around 12 million in the UK, lower back pain is commonly caused by damage to these intervertebral discs (IVD’s).

The UK economy can potentially save as much as £5 billion a year if a treatment can effectively cure the problem.

Using mesenchymal stem cells (MSCs) from adult bone marrow to regenerate spinal discs, the new therapy was developed by Dr. Stephen.

Bone, fat, muscle, and cartilage are among the many different types of tissues that can be grown from the multipotent MSC class of stem cells.

Dr. Stephen has succeeded in turning MSCs into the cells which make up the gel-like nucleus pulposus (NP) tissue separating the vertebrae.

Full patient trials will immediately follow the pre-clinical trials which are planned for next year.

Dr. Stephen said: “Once we have extracted the bone marrow from the patient and have purified the MSCs, they will be grown in culture and our patented method of differentiation will be applied.

“They will then be embedded within a gel which can be implanted back into the patient.”

There is no possibility of the stem cells being rejected by the immune system since they are taken from the patient’s own body.

Similar to one already used for the treatment of cartilage defects, the gel is based on a natural collagen.

It is implanted using an arthroscope, a thin tube device slipped through a small incision in the back.

“There is no reason why a patient should not return home on the same day as the procedure, or the day after,” said Dr. Stephen.

“Once implanted, the differentiated MSCs would produce a new NP tissue with the same properties as the original and would both treat the underlying cause of the disease and remove the painful symptoms.”

A combination of painkillers, physiotherapy, or surgery, is the current medical treatment for low back pain.

Vertebrae are fused together or tissue is removed to relieve the pain in sever cases.

Since the current techniques do not solve the root cause of the problem, success is limited.

Dries, research and information manager at the charity BackCare said that, “this is a really exciting area of research and although it is still early days, the initial results look very promising.”

Stem Cells, The Ultimate Anti-Aging Therapy

Degeneration and aging will be unraveled along with the other mysteries of life thanks to modern medicine. In Manila, a medical breakthrough has arrived with one of the latest developments in stem cell therapy.

Your body is in a constant state of renewal. The changes are occurring in your system even as you read this article. Inside the human body, cells renew, regenerate, and are born every single second.

Scientists have believed for quite some time now that when you die, the cells are not the same as when you were born.

So, why do we age if the natural process of the body is to remake itself? A team of stem cell biologists in Sweden are attempting to answer this question

It is suspected that stem cells age and their supply is exhausted. What happens if the supply is replenished? Enter stem cell therapy.

Our bodies are created from stem cells which are the fundamental building blocks of life. They develop into the different tissues of our body: bone, blood, nerve, muscle, organ, etc, and are formed at conception.

Injured tissue can be repaired by tapping the body’s stem cell reserves. However, the reserve becomes depleted since it is finite. Thus, we succumb to disease and aging as the regenerative power of the body decreases.

Bone marrow, peripheral blood, and fat are all sources of stem cells. The Russians were the first to collect stem cells from non-bone marrow sources. But the process raised ethical issues since the source was aborted fetuses.

Today, since it takes about five days to go through the process of harvesting bone marrow stem cells, a new approach has been tapped that is easier, just as effective, and non-controversial—Autologous Stem Cell Transplant.

This process was introduced in Manila by Dr. Florencio, who is a respected member of the medical community and a reputable senior plastic surgeon, along with an expert in regenerative medicine, Dr. Bill.

100cc’s of peripheral blood and fat are extracted from the body through mini-liposuction. The newly harvested inactive adult stem cells are incubated in stimulating growth factors derived from colostrums, which are the first liquid secretion of milk-producing organic cows in New Zealand.

Once 50 million stem cells are stimulated; the patient is infused with the isolated cells intravenously. Under local anesthesia, the procedure takes place in the operating room of a local hospital and lasts four hours. Three hours to incubate, stimulate, and infuse them back into the patient, with the other hour being occupied by the harvesting process.

The stem cells come from the individual and are returned to him/her, so there are no moral or religious issues involved.
Individuals with Parkinson’s, Alzheimer’s, cancer, arthritis, diabetes, and spinal cord injuries all stand to gain with this therapy.

In the case of an 80-year-old who has fewer tremors from Parkinson’s and now goes ballroom dancing, the results have been not only encouraging but astonishing. But it does not end with just one. Health enthusiasts, politicians, and high-profile businessmen that have received the treatment can now think faster and more clearly, their libidos have increased, and they have all gained a more youthful appearance.

A new medical breakthrough is being driven by the dynamic duo of Bill and Florencio. More extensive clinical studies are being planned for the near future.

Foreign patients are now flying to Manila to receive the benefits of the treatment.

“I chose to make Manila my headquarters because of its strategic location, ideal for medical tourism,” said Dr. Bill who was in Manila before for a World Health Organization project. “Filipino doctors are (also) among the finest in the world.” Specific study of stem cell therapy to ease pain and hasten wound-healing was allowed by working with the French Foreign Legion in Angola and Congo. Faster recovery and anti-aging results were observed.

But just how far back does the clock turn for stem cell patients? Right now, the number is five to ten years. But by improving the quality of their lives by making healthy decisions, the average human life expectancy can reach 120 without question.

Many individuals aspire to age gracefully, while others regardless of any health challenge, wish to improve the quality of their lives. But others are intrigued with the challenge of defying time itself.

So in the future, with advances in stem cell therapy, when someone asks the question, “how old are you?”

Your answer just may be, “I am as young as I want to be.”

Healing 101: Adult Stem Cells at the Forefront

A contentious topic in modern medicine, stem cell research is much debated. Embryonic stem cells and the controversy surrounding them has sparked curiosity in a less risky and more ethical option: using stem cells taken from adults to treat various diseases.

Understanding what the stem cell actually is, serves as a prerequisite to understanding the marvelous impact stem cells can have for modern medicine.

A single cell is the beginning of all life. A human being is an enormously complex organism and grows from just one fertilized egg. Special functions are carried out in each organ by specialized cells that “know” what to do. But stem cells are the original single cells and they can become any cells that we need them to be.

Our very first stem cell is in fact the fertilized egg. This single cell develops all the other cell types present within the human body. Adult stem cells have been collected from bone marrow for many years since adults still have stem cells in their tissues as the grow. The potential for these cells is tremendous.

Offering new parents a certain peace of mind by being saved or banked, adult stem cells can be found in the placenta and umbilical cord when babies are born. The stem cells can be transplanted without fear of rejection because cord blood stem cells are the child’s own. However, the number of cells that can be acquired is limited.

“It can save a child’s life if certain blood disorders develop in the early years, but there may not be enough cells to treat an older child,” Dr. Guerra explained. “Adult stem cells could hold the key to life-long health by facilitating treatment of devastating diseases and as a result increasing longevity.”

Heart disease, arthritis, osteoporosis, and many other diseases can be treated with banked adult stem cells on a future date. No concerns over finding a matching donor arise because a person’s own stem cells are used.

“A great benefit to using one’s own adult stem cells is the fact that you do not have to worry about rejection of cells since your own cells are used for your treatment,” noted Dr. Robin, M.D., M.B.A.

To place this in perspective, consider that less than 20 percent of patients who need a bone marrow transplant actually find a match in time to treat their disease.

Almost daily, new studies describing the clinical benefits of adult stem cells in the treatment of diseases are being published. Autologous stem cells are being researched in over 160 clinical trials. The possibilities of growing new skin, building cartilage, improving muscle, and regenerating the vital cells of a failing organ are being studied by countless research teams around the world.

Convenient stem cell banking methods are being driven by the growing interest in regenerative medicine. The results are promising so far.

73 percent of individuals with rheumatoid arthritis were able to be controlled on medication after being treated with stem cells as reported by The Journal of Rheumatology.

50 percent of patients with Lupus (SLE) treated with stem cells were disease-free five years after treatment as reported by The Journal of American Medical Association.

Adult stem cells have even repaired the vision of blind mice as the journal Nature reported recently.

Diseases such as diabetes, multiple sclerosis, and wound healing will likely bring more results and news after being treated with adult stem cells. Successful techniques could improve conditions that formerly decreased someone’s lifespan or quality of life, such as diabetes, blindness, Parkinson’s, Alzheimer’s; multiple sclerosis could be cured. We would have much less need for donor organs. Dr. Robin says that clinical trials are already under way in the cardiovascular department.

“As far as treatments go, great advances are being made in improving cardiac status of those individuals with end-stage heart disease and repairing the damaged tissue of those having heart attacks,” Dr. Robin said. “Additionally, you do not have the potential issue of tumor formation which has been seen with embryonic cells,” he added.

Adult stem cells, especially those stored from cord blood, are a bio-insurance for future use; and one that might just save your life. Through safe and non-invasive procedures, adults now have the option to collect and save their own cells.

Pumping Life Back Into The Heart With Adult Stem Cells

Now in his 50’s, Bobby didn’t want to lose his life to congestive heart failure. And his wife Gay, wanted her husband back.

Today, Bobby is a pioneer in a research study that — if the results continue to look promising — might transform heart treatment forever.

In an experimental procedure called myoblast cell transplantation, Bobby received injections in his heart of 100 million stem cells grown from his own leg muscle.

Since he received his own body’s cells, there is no rejection problems.

Many months and perhaps years stand in the way of having a stem cell procedure like this to enter mainstream medicine (after gaining approval by the FDA), but this much is a fact – Bobby’s scarred and dying heart muscle is regenerating.

Bobby, who has had four heart attacks, was the first one to receive 100 million cells out of the 24 people enrolled in the nationwide study. Testing safety through escalating doses, others have received 30 million, 300 million, and 600 million in phase one. Only patients with congestive heart failure caused by heart attacks were eligible for the experiment, keeping the study focus narrow.

Dr. Nabil, who performed part of this research at The Arizona Heart Institute in Phoenix said that Bobby’s results were extraordinary.

“I didn’t expect to see such improvement with 100 million cells. … Patients will respond differently, but the results are extremely encouraging, even with small doses.”

The procedure has nothing to do with embryonic stem cell research and instead uses cells cultured from the patient’s leg muscle.

“Over the last five years, we have developed a method to transplant the cells by catheter, like an angiogram. The patient can be awake and discharged the next day to go home,” Nabil said.

The researchers have proven they can isolate stem cells from the skeletal muscle and, “that the cells survive and make new muscle in a matter of three months,” he said.

The first two research centers in the United States to receive FDA approval to use 3-D guidance technology were The Arizona Heart Hospital and the Arizona Heart Institute. Allowing doctors to pinpoint the damaged areas of the heart with three-dimensional color mapping, the doctors can then inject myobalsts into the specific areas.

Cardiologists from around the world will visit Washington in February where Nabil will present a conference on the early study results.

Bobby traveled to Phoenix to be tested for the study after Gay’s research led her to Dr. Nabil in August of 2005. He was rejected for the study during an initial test due to a bad sunburn, but he was then accepted during a subsequent test and had a heart catheterization to map his heart.

A biopsy of his thigh muscle was taken in March of 2006. The cell culture was grown during the next four to six weeks in Boston from the marble sized sample of muscle.

His cells grew quickly and by April 6, he was back in Arizona for the injection of 100 million cells on April 7.

He doubled the amount he could walk in six minutes during tests last month. He had photos of his heart taken along with a stress test and an echocardiogram (pictured right). “After lunch I met with Dr. Nabil and Bee (a research coordinator) and they gave me my stats. They were as excited as they could be.

“He’s keeping an eye on me because they can’t figure out how I have so much stamina. I’m healthier than other patients he’s been working with,” Bobby said.

Bobby was referred to Vanderbilt University in 2002 where he met with Dr. Stacie, who was head of the cardiology and heart transplant unit at Vanderbilt. She said that Bobby was, “judged too weak for a heart transplant and his heart’s ejection fraction was down to 18 percent.” The ejection fraction is the rate at which the heart pumps.

55 percent is the average rate that a heart contracts.

His ejection fraction is up to 25 percent since his stem cell injections – a major improvement. “He’s in the early phases of something really big, and I view him as a pioneer,” Stacie said. “What Bobby is doing will help every patient who comes after him.”

Stem Cells Potential Cure for Muscular Dystrophy

With an advance that offers hope to hundreds of children crippled by the rare disease, scientists have successfully used stem cells to treat muscular dystrophy.

In a world first, dogs severely disabled by a canine variety of the condition, were able to walk freely, run, and even jump, after receiving stem cell injections.

Italian researchers said the first trials on children could commence within two years while British experts have described the results as “startling” and as a potential cure.

The most common form of the terminal condition is Duchenne muscular dystrophy. Affecting 100 babies born each year in the UK, the study focused on this particular form of the condition.

Youngsters become entirely incapable of walking by the age of 11 and most experience difficulty before the age of three. The muscle wasting disease is most common in boys.

Sufferers tend to die when they reach their 20’s due to the weakening of the heart and lung muscles. There is no known cure.

To regenerate wasted muscle, the study examined the ability of stem cells – master cells with the potential to develop into other types of cells.

Injections of stem cells were administered to golden retrievers suffering from a condition comparable to the human variety.

After a series of injections, those that had been in the early stages of the disease had not developed any symptoms, while previously crippled animals were able to jump and run.

The effects have opened the door for human trials said the researchers from San Raffaele Scientific Institute in Milan who were writing in the journal Nature.

Treatment of other types of muscular dystrophy and even age-related muscle wasting could be an extended approach.

More ethically acceptable than taking cells from an embryo, the human trials will use adult stem cells taken from the child or teenager.

Professor Dominic, of Imperial College London, said: “This exciting study is a major step forward in demonstrating the potential of stem cells to treat Duchenne muscular dystrophy, a fatal muscle wasting disease.”

Professor George, of the University of London, described the research as “startling in its simplicity and success”.

Dr. Peter, of Nottingham University, said: “The importance of this result is not only in providing a potential cure for a currently incurable condition but also in the use of adult stem cells.

“The use of these cells avoids the controversial use of embryonic stem cells. In addition, the relatively easy delivery of these cells via the blood stream makes this a viable method to treat human patients.”

Dr. Marita, of the Muscular Dystrophy Campaign charity, cautioned that research was still at an early stage.

She added: “If it does prove to be successful in humans, this technology has the potential to develop into an efficient and groundbreaking treatment not only for Duchenne, but also other muscular dystrophies.”

Womb Fluid Cells Used To Create Heart Valves

Offering a revolutionary advance that may be used to repair defective hearts in the future, scientists have grown human heart valves for the first time using stem cells from the fluid that cushions babies in the womb.

In order to have them ready to implant in a baby with heart defects after it is born, the thought is to generate these new valves in the lab while the pregnancy progresses.

The Swiss experiment suggests that people may one day be able to grow their own replacement heart parts — in some cases, even before they’re even born. Recent successes also include growing bladders and blood vessels.

The homegrown heart valves are more resilient and effective than artificial or cadaver valves; they are among several futuristic tissue engineering advances that could advance infant and adult heart treatment.

“This may open a whole new therapy concept to the treatment of congenital heart defects,” said Dr. Simon, a University of Zurich scientist who led the work, which was presented Wednesday at an American Heart Association conference.

In another first, Japanese researchers stated that they have grown new heart valves in rabbits using cells from the animals’ own tissue. It’s the first time replacement heart valves have been created in this manner, said lead author Dr. Kyoko.

“It’s very promising,” University of Chicago cardiologist Dr. Ziyad said of the two studies. “I don’t doubt” that it will be applied one day in humans, he said.

Killing more babies in the United States in the first year than any other birth defects, more than one percent, or 1 million babies, born worldwide each year have heart problems according to the National Institutes of Health.

Using ultrasound tests at about 20 weeks of pregnancy, the heart valve defects can be detected. And according to Simon, treatment with replacement valves would be feasible for at least one-third of afflicted infants have problems.

“It could be quite important if it turns out to work,” said Dr. Robert, a Northwestern University heart valve specialist.

There are drawbacks to conventional procedures for repairing faulty heart valves. Patients with artificial valves must take anti-clotting drugs for life because the valves are prone to blood clots. Repeating open-heart surgeries to replace heart valves is a problem with human cadaver valves or animal valves due to deterioration. And since cadaver and animals valves don’t grow along with the body, this is especially true in children, said Dr. Ziyad.

Valves made from the patient’s own cells are living tissue and might be able to grow with the patient, said Kyoko, a scientist at the National Cardiovascular Center Research Institute in Osaka.

The Swiss procedure has another advantage: Using cells the fetus sheds in amniotic fluid avoids controversy because it doesn’t involve destroying embryos to get stem cells.

“This is an ethical advantage,” Simon said at the meeting.

The experiment began with amniocentesis, which is a prenatal test for birth defects that is often offered to pregnant women aged 35 and older. The amniotic fluid was obtained this way by inserting a needle into the womb during this procedure.

Fetal stem cells were isolated from the fluid, cultured in a lab dish, then placed on a mold shaped like a small ink pen and made of biodegradable plastic. Growing each of the 12 valves created in the experiment took only four to six weeks.

The valves appeared to function normally during lab testes said researchers.

A new two-year experiment is underway involving valve transplants in sheep. Simon says it is the next step.

He and co-researcher Dorthe called their method “a promising, low-risk approach enabling the prenatal fabrication of heart valves ready to use at birth.”

Simon said amniotic stem cells also can be frozen for years and could potentially be used to create replacement parts for aging or diseased valves in adults

Experts say implanting tissue-engineered human valves in human hearts is likely years away, but the research is only preliminary. Despite the experts, the treatment is not as far-fetched as it sounds.

Earlier this year, U.S. scientists used tissue grown from the patient’s own cells to re-engineer seven diseased bladders.

And last year, created from their own skin and vein tissue, two kidney dialysis patients from Argentina received the world’s first tissue-engineered blood vessels.

Dr. John, a Children’s Hospital Boston heart surgeon and tissue engineering pioneer, said scientists are optimistic that this area of research will revolutionize how people with valve disease will be cared for in the future.

According to John, each year more than 250,000 patients worldwide have surgery to replace heart parts.

In one of John’s experiments, sheep were implanted with heart valves fashioned from stem cells harvested from sheep bone marrow. The valves appeared to function normally. Cells harvested from sheep arteries were used in a similar experiment.

Amniotic fluid has the potential to be a richer supply of stem cells in contrast to other sources says Simon.

The real test will be to see whether or not valves created from amniotic fluid will be superior to those made from other cell types said John.

“I’m pretty sure the ball will continue to be advanced down the field,” John said. “We’ll get there one way or the other.”

Heart Transplants Could Become History With The Use of Adult Stem Cells

According to a study on how to repair the effects of cardiac failure, stem cells taken from a patient’s own body could help restore the health of a malfunctioning heart.

To replace damaged heart tissue, scientists have shown that it is possible to grow cardiac stem cells in the laboratory prior to transplanting them back into a patient.

Offering an alternative treatment to a complete heart-transplant operation, the findings demonstrate the prospect of rebuilding cardiac muscle that had been destroyed during a heart attack.

Since a pig’s heart is so similar to the human heart, the experiment was conducted on pigs. But the researchers involved said that clinical trials on people could begin in 12 months’ time.

The technique involves taking a small biopsy – a sample of living heart muscle – that is no bigger than a grain of rice said Professor Eduardo, head of cardiology at the Johns Hopkins University School of Medicine in Baltimore, Maryland.

Using a standard method of accessing the organ through a catheter inserted into an artery in the leg, an infusion of stem cells was put into the animal’s heart. The stem cells were derived from a biopsy and then grown in the laboratory prior to infusion.

“This is a relatively simple method of stem cell extraction that can be used in any community-based clinic, and if further studies show the same kind of organ repair that we see in pigs, it could be performed on an outpatient basis,” Professor Eduardo said.

“Starting with just a small amount of tissue, we demonstrated that it was possible, very soon after a heart attack, to use the healthy parts of the heart to regenerate some of the damaged parts,” he said.

The stem cells in the experiment were labeled with a colored dye so that the scientists could see where they became integrated into the structure of the heart. The cells were cultured for up to a month in the laboratory.

About 10 million cells were injected back into the heart after growing them in the laboratory. The preliminary biopsy extracted about a million stem cells initially. After infusion, the stem cells were still embedded in functioning tissue two months later.

Professor Eduardo said that rather than measuring the physical benefits, the purpose of the experiment was to see whether or not the integration occurred. An examination of the therapeutic qualities of the infusion will form the next stage of the experiment.

“But we have proof of principle, and we are planning to use larger numbers of cells implanted in different sites of the heart to test whether we can restore function as well,” Professor Eduardo said.

“If the answer is yes, we could see the first phase of studies in people in later 2007,” he said.

As the undifferentiated cells of the body, stem cells are capable of forming specialized tissues, such as cardiac muscle.

Taking adult stem cells from a patient’s own heart could provide an alternative to using stem cells taken from a cloned human embryo.

Among other advantages, the transplanted tissue will not be rejected by the body’s immune system since the patient will be using his or her own cells. This will eliminate the need for potentially damaging drugs.

“The goal is to repair heart muscle weakened not only by heart attack but by heart failure, perhaps averting the need for heart transplants,” said Peter of the Hopkins’ Heart Institute.

“By using a patient’s own adult stem cell rather than a donor’s, there would be not risk of triggering an immune response that could cause rejection,” he said.

The results of the study were released yesterday at the American Heart Association’s annual meeting in Chicago.

Three Blind Mice No Longer, Adult Stem Cells Restore Sight

Scientists from the Institutes of Ophthalmology and Child Health (University College London) and Moorfield’s Eye Hospital in London performed retinal stem cell transplants on blind mice in an attempt to restore their vision. The procedure was successful and reversed their condition. Humans blinded by diabetes or age-related macular degeneration have renewed hope as the results of this study could ultimately lead to sight restoration for those individuals.

The journal Nature has published the complete study.

The mice suffered from a type of eye damage which is a common cause of human blindness – photoreceptor loss.

Preventing or delaying the loss of the cone and rod photoreceptors is the existing focus of treatment for individuals who are losing their eyesight. But for people who have already lost their vision, there is no present medical procedure to restore their sight. The study may help blind individuals regain the cone and rod photoreceptors in the retina – and see again.

Connections to the brain are there even when the photoreceptors are gone, so in the world of cell transplant, the retina is considered to be a good candidate. Some of the parts may be missing, but he wiring is still there. Previous trials were unable to develop photoreceptor cells because the cells were too immature.

This time, the cells were set up so that they would develop into photoreceptors. The transplant cells were still immature, but less so than before in the new study. 3-day-old mice provided the cell samples from the retina. The blind mice were then given the cells via transplant directly into the eyes.

Gradually, the mice began to recover their eyesight. Scientists were able to conclude this because when the mice were exposed to light, their pupils contracted.

The scientists aim to find a way of using adult stem cells in order to see whether this can be done with humans. Another method would be to use cells from a fetus that is 3-6 months old; however, the scientists will not pursue this avenue for ethical reasons.

The scientists say that adult retinas have areas with cells that might be usable. They also added that there will be extensive research before and reliable medical procedure is offered to patients.

Man Gains Strength and Confidence After Adult Stem Cell Heart Procedure

With the hope of extending his stay in this world a little longer, Dick has finished a journey of a lifetime; a trip to the opposite end of the world and back.

The 70 year old Dick received treatment with a new procedure in which adult stem cells extracted from his own blood were injected directly into his ailing heart to strengthen it. A heart specialist in Bangkok, Thailand, performed the procedure on September 26th. Prior to Dick’s operation, the Bangkok Heart Institute had only done 80 of these operations.

Accompanied by his son Dusti, the two of them stayed in Bangkok for almost four weeks as Dick underwent and recovered from the process.

Gaining strength and in good spirits, Dick returned home on October 10th. He is hoping the operation will give him more energy and extend his life by rejuvenating his heart.

“Things weren’t going well,” says Dick.

He still loves to go inline skating, play golf, and is a life long athlete. But as a child, he was afflicted with rheumatic fever twice. His heart was weakened, and after getting two artificial valves and then a pacemaker during operations in recent years, he suffered a stroke this spring on a golf course in Florida. Dick’s heart was only functioning at about 11 percent of its total capacity by late summer.

“For the last year or so my dad’s been talking about having the stem cell procedure done,” Dusti said. “He had read articles and was fascinated with it. Finally we were to the point where his cardiologist in Springfield said we had done all we can. My dad had had two mechanical valves and a pacemaker put in. Things weren’t going well at all.”

Three out of the four Bangkok doctors that Dick asked to perform the procedure on him, refused, due to his age and frailty. There are two types of procedures done – a direct injection where they are injected directly into the heart, or a coronary procedure where stem cells injections are administered directly into the arteries.

Dick was accepted and approved for the direct injection procedure by a Bangkok cardiologist named Dr. Permyos. The next step was making the 30-hour flight to Bangkok on September 15th.

After blood was drawn and the stem cells harvested, the doctors began administering the injections. It was not easy due to a large quantity of scar tissue surrounding his heart from past surgeries.

“Normally they do 10 injections, but mine took 30,” Dick said. “The operation normally takes about 15 minutes, but for me it was over two hours.”

For now, the Watson family is encouraged by Dick’s continued recovery. Just before the surgery he weighed 96 pounds and now he has gained another 15. Three times a week, he goes to physical therapy sessions in Galesburg. He should have a better idea as to how his body is handling the cells injected into his heart in late December, three months after the surgery. According to his doctors, his heart should be working at a about a 21 percent rate at the three month mark – this would be considered a success.

“We were very optimistic,” Dusti said. “Before we went, he felt he was at the point where he was sitting around at his home with his head down, very tired. We felt he was down to a month or two left to live. He was not doing well at all, but we were very optimistic. They told us there was a 10 percent chance of death from the procedure and that there was no guarantee this procedure will work. But they said of the 80 procedures they’d done, it had been effective on 85 percent on them.”

Now, within a days drive all over the Midwest, Dusti is back at his job fixing pipe organs. The third-generation family company, Watson Pipe Organ Sales and Service, was started by his grandfather in 1929. Dick is retired from the company, but Dusti still works on about 95 organs regularly. The normal routine is starting to settle in. Dusti and his wife Julie, along with their two children met up with Dick and his wife Patti for pizza a week ago.

“I think (this procedure) is remarkable,” Dusti said. “There are other methods of harvesting stem cells but when they come from your own blood, the compatibility issues would be great.”
The procedure is the future of cardiac treatment said Dick’s doctors.

“Though stem cell procedures still are not commonly done, people like me will help change it,” Dick said. “I think it will cut way down on heart transplants.”

Dick’s attitude and faith have been helpful with his recovery.

“He has a very strong faith and always had a very positive attitude,” Dusti said. “He knew thousands of people were praying for him and he was so grateful. Every day I’d read the comments people would post on the Web site. I think a strong faith and a positive attitude are paramount. It definitely helped him. I know as he gets stronger he hopes to share his story with people to help them.”

Amputation Prevented Due to Adult Stem Cells

Suffering from critical limb ischemia, a diabetic faced the loss of a lower limb. But a private hospital in Chennai saved the patient by using bone marrow stem cell treatment.

“The 68-year-old woman, hailing from Andhra Pradesh and suffering from critical ischemia, with a very large ulcer at the left calf and foot and advised amputation of the left lower limb, successfully underwent autologous (one’s own) bone marrow stem cell treatment at the vascular department of Chennai’s Vijaya Hospital,” the hospital’s chief vascular surgeon, Dr. Subrammaniyan, said recently.
New blood vessel formation improved circulation to the affected leg and the women’s ulcer healed in 60 days.

A team of doctors assisted Dr. Subrammaniyan as bone marrow was injected into the affected portion of the woman’s calf muscle after it was tapped under general anesthesia. Due to the patients advanced condition, bypass surgery to salvage the limb was ruled out. The 100ml dose of bone marrow was repeated a month later.

Health granulation started covering the previously ischemic portion as the healing process commenced very rapidly said the doctors. Close to 40 per cent of the foot area, 20 per cent of the calf area and 100 per cent of the lateral wound had been covered with skin. The remaining portion healed successfully and was treated with skin grafting.

“The patient is now able to use her left foot,” he said.

Dr. Subrammaniyan claimed that 20 percent of the country’s population would be diabetic by 2015. The treatment alone would cost about INR 50,000 (about $1,100 U.S. dollars) he added.